ArticleTranslational pediatrics2026
Eosinophil-derived neurotoxin as a biomarker to predict the development of asthma after respiratory infection in infant.
Article in Translational pediatrics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Respiratory tract infection in infancy can cause symptomatic wheezing or asthma later in childhood. In recent years, eosinophil-derived neurotoxin (EDN) has been proposed to play a role in the development of asthma, however, this fact remains unclear. Therefore, this study aimed to determine whether EDN is a biomarker to predict asthma following respiratory tract infections in infants. Methods: From October 2021 to March 2022, we tracked children hospitalized for respiratory tract infections at the Chengdu Women's and Children's Central Hospital. All patients underwent medical history collection and EDN testing, and were followed up at 6 months, 1 year and 3 years post-discharge. Multifactor analysis was subsequently conducted using multivariate logistic regression and receiver operating characteristic (ROC) analysis. Results: A total of 183 participants were enrolled in this study. Statistical data showed that EDN levels were significantly higher in the asthma group (P<0.001). Multivariate regression analysis revealed that EDN, number of wheezing within 6 months, and allergy history were independent risk factors for asthma development following respiratory tract infections in children. Further ROC curve analysis demonstrated that EDN has predictive value for asthma occurrence, and combining it with number of wheezing within 6 months and allergy history can further enhance its predictive efficacy. Conclusions: EDN may be a useful biomarker to predict the development of asthma following respiratory tract infections in infants and could be used as a useful screening tool for asthma in young children.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.